Skip to main content
enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
6.96
-0.24 (-3.33%)
At close: Apr 28, 2026, 4:00 PM EDT
6.96
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:47 PM EDT

enGene Therapeutics Employees

As of October 31, 2025, enGene Therapeutics had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.

Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,493,146
Market Cap
466.25M

Employees Chart

Employees History

Date Employees Change Growth
Oct 31, 2025822543.86%
Oct 31, 2024572472.73%
Oct 31, 202333--

Related Stocks

Company Name Employees
Ginkgo Bioworks Holdings 485
4D Molecular Therapeutics 196
ADC Therapeutics 193
Entrada Therapeutics 152
Verastem 102
Larimar Therapeutics 71
Candel Therapeutics 55
Contineum Therapeutics 51
Employee Rankings

ENGN News

More News